Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

80 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q2 2021.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25.4M shares of 266M outstanding shares and own 9.53% of the company stock.
Largest 10 shareholders include Capital World Investors (2.96M shares), CITADEL ADVISORS LLC (2.76M shares), Polygon Management Ltd. (2.5M shares), FRAZIER MANAGEMENT LLC (2.28M shares), FMR LLC (2.07M shares), Nantahala Capital Management, LLC (1.79M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.67M shares), Ikarian Capital, LLC (1.36M shares), JPMORGAN CHASE & CO (751K shares), and MILLENNIUM MANAGEMENT LLC (725K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.